Company: HYEX
Filing Date: 2025-04-22
Form Type: 10-K/A
Source: 0001096906-25-000553
Chunk: 56

Company: HEALTHY EXTRACTS INC.
Filing Date: 2025-04-22
Form: 10-K/A
Chunk 56
---
2024 was $(189,389), compared to $369,539 for the year ended December 31, 2023. Our net cash provided by financing activities consisted primarily of proceeds from the issuance of notes payable of $94,000 and proceeds from the issuance of notes payable related party of $314,800, offset by repayment of notes payable of $489,123 and repayment of convertible debt of $103,666. ITEM 7A – QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK As a smaller reporting company, we are not required to provide the information required by this Item. 47 ITEM 8 - FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

| Report of Independent Registered Public Accounting Firm                           
 Balance Sheets as of December 31, 2024 and 2023                                   
 Statement of Operations for the years ended December 31, 2024 and 2023            | F-1         
 F-2         
 F-3         |
|:----------------------------------------------------------------------------------|:------------|
| Statement of Stockholders’ Deficit for the years ended December 31, 2024 and 2023 | F-4         |
| Statement of Cash Flows for the years ended December 31, 2024 and 2023            | F-5         |
| Notes to Financial Statements                                                     | F-6 to F-24 |

48 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To all Board of Directors and Shareholders Healthy Extracts Inc. OPINION ON THE FINANCIAL STATEMENTS We have audited the accompanying consolidated balance sheets of Healthy Extracts Inc. (the “company”)as of December 31, 2024 and 2023, and the related consolidated statements ofincome, stockholders’ equity, and cash flows for the years then ended December 31, 2024 and 2023 and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of Healthy Extracts Inc. as of December 31, 2024 and 2023, and the results of its operations and its cash flows for the years ended December 31, 2024 and 2023, in conformity with accounting principles generally accepted in the United States of America. BASIS FOR OPINION These financial statements are the responsibility of the entity’s management. Our responsibility is to express an opinion on these financial statements based on our audits. We